Found: 26
Select item for more details and to access through your institution.
A peptide derived from hepatitis C virus (HCV) core protein inducing cellular responses in patients with HCV with various HLA class IA alleles.
- Published in:
- Journal of Medical Virology, 2009, v. 81, n. 7, p. 1232, doi. 10.1002/jmv.21518
- By:
- Publication type:
- Article
Phase II Study of Personalized Peptide Vaccination with Both a Hepatitis C Virus-Derived Peptide and Peptides from Tumor-Associated Antigens for the Treatment of HCV-Positive Advanced Hepatocellular Carcinoma Patients.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Long-term outcome of elderly patients (75 years or older) with hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2014, v. 44, n. 9, p. 975, doi. 10.1111/hepr.12279
- By:
- Publication type:
- Article
Radiofrequency ablation combined with transarterial chemoembolization for intermediate hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2014, v. 44, n. 2, p. 194, doi. 10.1111/hepr.12100
- By:
- Publication type:
- Article
Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b<sup>+</sup> HLA-A24<sup>+</sup> patients.
- Published in:
- Hepatology Research, 2007, v. 37, n. 3, p. 186, doi. 10.1111/j.1872-034X.2007.00018.x
- By:
- Publication type:
- Article
Identification of hepatitis C virus 1b-derived peptides recognized by both cellular and humoral immune systems in HCV1b<sup>+</sup> HLA-A24<sup>+</sup> patients
- Published in:
- Hepatology Research, 2005, v. 32, n. 4, p. 227, doi. 10.1016/j.hepres.2005.06.003
- By:
- Publication type:
- Article
Development of Lobular Panniculitis Long After Completing the Personalized Peptide Vaccine Therapy.
- Published in:
- American Journal of Case Reports, 2018, v. 19, p. 1530, doi. 10.12659/AJCR.912418
- By:
- Publication type:
- Article
Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients' Conditions in Advanced Pancreatic Cancer under Personalized Peptide Vaccine.
- Published in:
- Evidence-based Complementary & Alternative Medicine (eCAM), 2013, v. 2013, p. 1, doi. 10.1155/2013/981717
- By:
- Publication type:
- Article
Immunological evaluation of personalized peptide vaccination for patients with histologically unfavorable carcinoma of unknown primary site.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 10, p. 1223, doi. 10.1007/s00262-016-1887-5
- By:
- Publication type:
- Article
A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11, -A31, and -A33.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1359, doi. 10.1007/s00262-007-0284-5
- By:
- Publication type:
- Article
Carboplatin as an Anticancer Agent for Transcatheter Arterial Chemoembolization in Patients with Hepatocellular Carcinoma.
- Published in:
- Oncology, 1997, v. 54, n. 1, p. 28, doi. 10.1159/000227657
- By:
- Publication type:
- Article
Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis.
- Published in:
- Cancer (0008543X), 2002, v. 95, n. 3, p. 588, doi. 10.1002/cncr.10694
- By:
- Publication type:
- Article
Elevation of Serum MAGE-4 Protein Levels and Prediction of Hepatocellular Carcinogenesis in Patients with Liver Cirrhosis.
- Published in:
- Cancer Science, 2002, v. 93, n. 4, p. 453, doi. 10.1111/j.1349-7006.2002.tb01277.x
- By:
- Publication type:
- Article
Expression of the tumor-rejection antigen SART1 in brain tumors.
- Published in:
- International Journal of Cancer, 1999, v. 83, n. 6, p. 760, doi. 10.1002/(SICI)1097-0215(19991210)83:6<760::AID-IJC11>3.0.CO;2-R
- By:
- Publication type:
- Article
Identification of biomarkers for personalized peptide vaccination in 2,588 cancer patients.
- Published in:
- International Journal of Oncology, 2020, v. 56, n. 6, p. 1479, doi. 10.3892/ijo.2020.5019
- By:
- Publication type:
- Article
Serum levels of IgG to the peptide of HCV1b core at positions 35–44 correlated with persistent infection, while levels of IgG to the peptide of NS5A at positions 2132–2140 correlated with better prognosis in HCV-infected patients.
- Published in:
- Medical Microbiology & Immunology, 2007, v. 196, n. 3, p. 157, doi. 10.1007/s00430-007-0038-1
- By:
- Publication type:
- Article
Personalized Kampo Medicine Facilitated Both Cytotoxic T Lymphocyte Response and Clinical Benefits Induced by Personalized Peptide Vaccination for Advanced Esophageal Cancer.
- Published in:
- Evidence-based Complementary & Alternative Medicine (eCAM), 2016, v. 2016, p. 1, doi. 10.1155/2016/5929525
- By:
- Publication type:
- Article
Immune responses of patients without cancer recurrence after a cancer vaccine over a long term.
- Published in:
- Molecular & Clinical Oncology, 2022, v. 16, n. 6, p. N.PAG, doi. 10.3892/mco.2022.2545
- By:
- Publication type:
- Article
Investigation of factors associated with reduced clinical benefits of personalized peptide vaccination for pancreatic cancer.
- Published in:
- Molecular & Clinical Oncology, 2021, v. 14, n. 2, p. N.PAG
- By:
- Publication type:
- Article
Survival analysis of multiple peptide vaccination for the selection of correlated peptides in urological cancers.
- Published in:
- Cancer Science, 2018, v. 109, n. 9, p. 2660, doi. 10.1111/cas.13709
- By:
- Publication type:
- Article
Personalized peptide vaccination as second-line treatment for metastatic upper tract urothelial carcinoma.
- Published in:
- Cancer Science, 2017, v. 108, n. 12, p. 2430, doi. 10.1111/cas.13404
- By:
- Publication type:
- Article
Feasibility study of personalized peptide vaccination for hepatocellular carcinoma patients refractory to locoregional therapies.
- Published in:
- Cancer Science, 2017, v. 108, n. 9, p. 1732, doi. 10.1111/cas.13301
- By:
- Publication type:
- Article
A randomized phase II trial of personalized peptide vaccine with low dose cyclophosphamide in biliary tract cancer.
- Published in:
- Cancer Science, 2017, v. 108, n. 5, p. 838, doi. 10.1111/cas.13193
- By:
- Publication type:
- Article
Immunological evaluation of peptide vaccination for cancer patients with the HLA -A11<sup>+</sup> or -A33<sup>+</sup> allele.
- Published in:
- Cancer Science, 2017, v. 108, n. 4, p. 598, doi. 10.1111/cas.13189
- By:
- Publication type:
- Article
Immunological evaluation of peptide vaccination for cancer patients with the HLA-A26 allele.
- Published in:
- Cancer Science, 2015, v. 106, n. 10, p. 1257, doi. 10.1111/cas.12757
- By:
- Publication type:
- Article
Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles.
- Published in:
- Cancer Science, 2009, v. 100, n. 10, p. 1935, doi. 10.1111/j.1349-7006.2009.01256.x
- By:
- Publication type:
- Article